For years, glucagon receptor antagonists have been favored as a treatment for both type 1 diabetes and type 2 diabetes, consistent with the idea that hepatic glucagon elevates glycemia, so blocking its effect could lower glycemia and improve glucose control
Regardless of BMI at baseline, GLP-1 drugs were associated with a lower risk of VTE at 12 months
Ask what diagnosis is being treated, what evidence supports the option, whether imaging or rehabilitation is needed, whether the source is legitimate, what risks apply to your health history, how progress will be measured, and what the plan is if symptoms do not improve
Its also how you build habits that survive beyond medication
From the very first application, my skin felt noticeably smoother, more hydrated, and visibly radiant